OpenVSafe by OpenVAERS
Search V-safe

CQ2-20454-22752

4 vaccinations 7 coded responses 23 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
064 / CT
Registered
2021-02-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-13
    Registered in v-safe
  3. 2021-02-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-02-19
    Dose 2 — Pfizer-BioNTech
  5. 2021-02-19
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-02-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pain in extremity — Feeling: Good · Muscle or body aches
    Free text: Aching forearms, especially a few hours after 2nd dose. Symptom has diminished since.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-02-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising — Feeling: Good
    Free text: Some bruises at injection sight and elsewhere on the same arm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-26
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-03-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-19
    Survey response — day 28, dose 2
    MedDRA: Condition aggravated, Fatigue, Headache, Pain, Pre-existing disease, Restlessness, Sleep disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Restless Leg Syndrome worse than usual (every night rather than 1-2 nights per week and disrupting sleep. Headaches (could be seasonal allergies). Fatigue and body aches.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-21
    Survey response — 3 months, dose 2
    MedDRA: Tinnitus — Feeling: Good
    Free text: Tinnitus slightly more noticeable
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-08-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-11-15
    Dose 3 — Pfizer-BioNTech
  21. 2022-02-19
    Survey response — 12 months, dose 2
    MedDRA: Pain — Feeling: Good
    Free text: persistent body aches (not debilitating, but new and/or unusual
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-06-11
    Dose 4 — Pfizer-BioNTech
  23. 2022-06-28
    Survey response — day 14, dose 4
    MedDRA: Pain — Feeling: Good
    Free text: After 4th dose, unusual body aches and pains, but nothing that impaired daily function
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-07-14
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  25. 2022-07-17
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  26. 2022-07-23
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  27. 2022-12-11
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  28. 2023-06-11
    Survey response — 12 months, dose 4
    MedDRA: Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-29Pfizer-BioNTech
22021-02-19Pfizer-BioNTech
32021-11-15Pfizer-BioNTech No
42022-06-11Pfizer-BioNTech No

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-21

Systemic reaction (other): Aching forearms, especially a few hours after 2nd dose. Symptom has diminished since.

2021-02-24

Systemic reaction (other): Some bruises at injection sight and elsewhere on the same arm

Release 5 — day 28, dose 2

2021-03-19

Symptoms: Restless Leg Syndrome worse than usual (every night rather than 1-2 nights per week and disrupting sleep. Headaches (could be seasonal allergies). Fatigue and body aches.

Release 8 — 3 months, dose 2

2021-05-21

Symptoms: Tinnitus slightly more noticeable

Release 11 — 12 months, dose 2

2022-02-19

Symptoms: persistent body aches (not debilitating, but new and/or unusual

Release 12 — day 14, dose 4

2022-06-28

Symptoms: After 4th dose, unusual body aches and pains, but nothing that impaired daily function

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPre-existing disease ✓ · ✓
SDRestlessness ○ ✓ ○
SDSleep disorder ✓ ✓ ✓
SDTinnitus ✓ ✓ ✓
SROInjection site bruising ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release